Nacfc 2020 How Genetic Based Therapies Could Restore Cftr Function

Summary

To lay the foundation for the Path to a Cure, an ambitious initiative to accelerate Bill Skach, MD, executive vice president and chief scientific officer at the Cystic Fibrosis Foundation, talks about developing ... As we learn more about variation within the Until recently, only about 60 percent of the cystic fibrosis population was eligible for In 2019, we launched the Path to a Cure which centers around three core strategies to address the underlying cause of cystic ... The recent success of highly effective modulator This session helps attendees understand cystic fibrosis by describing how genes are translated into proteins. Speakers explain ...